Who owns cytel?
Nordic Capital
Nordic Capital and Astorg today announced an agreement to jointly acquire Cytel Inc. (“Cytel”), from New Mountain Capital. Cytel is one of the largest providers of statistical software and advanced analytics for clinical trial design and biometrics execution.
What does cytel do?
Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have helped biotech and pharmaceutical companies navigate uncertainty, prove value and unlock the full potential of their data.
What is East software?
Used by statisticians worldwide for over 30 years, East® is the leading software tool for designing statistically optimized clinical trials. Designed by statisticians for statisticians, these are modules which deliver trusted results.
Where is cytel located?
Cambridge, Massachusetts
Cytel is a multinational statistical software developer and contract research organization, headquartered in Cambridge, Massachusetts, USA.
Who is the CEO of Cytel?
Joshua Schultz
Cytel announced the appointment of Joshua Schultz as Chief Executive Officer (CEO) effective January 7th, 2019. He succeeds Joseph Avellone, who acted as Cytel’s interim CEO from March 2018 and will continue to serve on the company’s Board of Directors.
What kind of software is Cytel used for?
Cytel From Wikipedia, the free encyclopedia Cytel is a multinational statistical software developer and contract research organization, headquartered in Cambridge, Massachusetts, USA. Cytel provides clinical trial design, implementation services, and statistical products primarily for the biotech and pharmaceutical development markets.
How does Cytel help in clinical trial design?
Cytel transforms intelligence into confident decisions through the use of intelligent software solutions for clinical trial design and intelligent services for strategic guidance.
Who are the founders of the company Cytel?
Company founders Cyrus Mehta, Ph.D. and Nitin Patel, Ph.D. are amongst the pioneering statisticians credited for developing the underlying statistical methods behind so-called “flexible” designs: group sequential and adaptive trials. Cytel statisticians have collectively published over 140 papers in peer-reviewed statistical and medical journals.
What does Cytel do as a consulting arm?
Cytel’s Consulting arm focuses on optimizing the approach for biopharma clinical research development objectives. Functional elements their Strategic Consulting team claims to provide include:
